Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study

INTRODUCTION: The soluble urokinase-type plasminogen activator receptor (suPAR) has recently been associated with a decline in kidney function and incidence of chronic kidney disease in patients with cardiovascular disease undergoing cardiac catheterization, yet little is known whether suPAR is asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Christina-Alexandra, Persson, Margaretha, Christensson, Anders, Hindy, George, Almgren, Peter, Nilsson, Peter M., Melander, Olle, Engström, Gunnar, Orho-Melander, Marju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362148/
https://www.ncbi.nlm.nih.gov/pubmed/28367534
http://dx.doi.org/10.1016/j.ekir.2016.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362148/
https://www.ncbi.nlm.nih.gov/pubmed/28367534
http://dx.doi.org/10.1016/j.ekir.2016.11.004

Ejemplares similares